LifeMD, Inc. — Director's Dealing 2018

Mar 28, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Immudyne, Inc. (IMMD)
CIK: 0000948320
Period of Report: 2018-03-27

Reporting Person: Schreiber Justin (Director, Chief Executive Officer, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-03-27	Common Stock, par value $0.01	P	212500	$0.26	Acquired	2831193	Indirect